Compound Detail
CHEMBL4297803
PEGZILARGINASE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL4297803 |
| Name | PEGZILARGINASE |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
6
Known Names
6
Indications
1
Mechanisms
Drug Information
| Molecule Type | Enzyme |
| First Approval | 2023 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| L-arginine hydrolytic enzyme | HYDROLYTIC ENZYME | L-arginine | ✓ | ✓ |
Indications
Hyperargininemia Leukemia, Myeloid, Acute Myelodysplastic Syndromes Neoplasms Neoplasms Small Cell Lung Carcinoma
ATC Classification
A16AB24
pegzilarginase
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
Data from ChEMBL 36 via Core Engine